A New Era in Weight Loss Treatment Reaches 25 European Countries

A Swedish healthtech company is opening the doors to a new chapter in medical weight loss and preventive care. With modern medications, digital accessibility and a team of experienced specialists, FagerCare offers something the market has been missing for a long time: professional treatment without bureaucratic hurdles, without lock-in contracts and without breaking the bank.

When the new GLP-1 medications – Mounjaro, Ozempic and their counterparts – had their breakthrough, the rules of weight loss changed for good. The results are well-documented and impressive. Yet access has been uneven, costly and tangled in red tape. FagerCare was founded on a single idea: making these treatments available to those who genuinely need them, on terms that actually work.

What FagerCare Offers

FagerCare is a digital healthcare service focused on medical weight loss, with particular emphasis on the latest pharmaceutical treatments. The service is aimed at adults dealing with excess weight who want qualified medical support – without long waiting lists, expensive private clinics or binding contracts.

Becoming a patient is straightforward by design. It begins with a digital consultation with a licensed physician, followed by an individual assessment, and – where treatment is warranted – a prescription. From that point, the patient chooses the next step that fits them best.

One of the model’s defining strengths is the freedom to collect medication from any pharmacy, including online pharmacies, and thereby pick whichever option is cheapest at the time. With medication prices varying widely between providers today, that flexibility can translate into significant annual savings. No lock-in. No hidden fees. Just care on the patient’s terms.

The People Behind the Service

FagerCare rests on solid medical and technical foundations. Dr Frida Fagerdahl is a specialist physician in family medicine with broad experience in metabolic health. She represents the clinical core of the company and ensures that every patient’s treatment is grounded in science and individual judgement.

Specialist Tony Fagerdahl contributes deep expertise in health and treatment methodology, reinforcing the holistic view of patient wellbeing that runs through everything the company does.

Marcus Everflod, CEO of Searchminds, is responsible for the entire digital infrastructure. Searchminds builds and develops the company’s digital solutions – from platforms and patient flows to online visibility and presence. Thanks to this partnership, patients across Europe enjoy a seamless and secure digital experience.

Europe as Home Ground

FagerCare is already active in 25 European countries. This is not a future plan – it is current reality. For people living abroad, moving between countries or simply preferring digital health management, the difference is decisive. Whether you find yourself in Stockholm, Málaga or Milan, the same quality of care is available.

Online Pharmacy and Expanded Services on the Way

Over the coming year, FagerCare is set to expand significantly. A partnership with an online pharmacy is under development and launching soon – a natural next step that simplifies the entire chain from consultation to treatment. Alongside this, new services are being added continuously. The company is in constant motion, with the ambition to keep broadening what it can offer its patients.

Longevity – Living Better, Not Just Longer

One of the more exciting dimensions of FagerCare’s offering is the growing focus on longevity – a concept that in recent years has moved from niche biohacking culture to one of medicine’s most discussed frontiers. Longevity is the science and practice of extending not just lifespan, but above all the healthy and active part of life – what is known as healthspan.

Through combinations of biomarker analysis, nutritional and exercise intervention, and targeted supplements and medications, the approach is preventive rather than reactive. Research in the field – led by figures such as David Sinclair and Peter Attia – suggests that ageing itself can be slowed, and that we have far greater control over our biological age than previously assumed. FagerCare integrates this perspective into its work and offers patients access to longevity-focused services as a complement to primary treatments. It is about treating health as a long-term project, not merely the management of acute conditions.

An Exclusive Clinic Opening This Autumn

Perhaps the most ambitious news is the opening of an exclusive physical and digital clinic, planned for the end of summer 2025. The clinic is aimed at patients with chronic conditions – those who have lived with pain, fatigue, autoimmune disorders or other long-term health issues and are looking for more in-depth, individualised support.

The concept is built on the conviction that under the right conditions, the body has a remarkable capacity to heal. The clinic will offer advanced assessment and tailor-made treatment plans, with the goal of not merely managing symptoms but actually addressing root causes.

Why FagerCare?

In a landscape of healthcare options that are either hard to access, impersonal or prohibitively expensive, FagerCare offers something genuinely different. The combination of licensed medical expertise, digital accessibility, pricing flexibility and a steadily growing range of services makes the company one of the most complete options for anyone who takes their health seriously.

With operations in 31 countries, an online pharmacy on the way, an exclusive clinic in sight and a platform built by one of Europe’s most experienced digital companies – Searchminds – FagerCare is well positioned for what comes next. More information is available at Fagercare.